Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
Fifth-order susceptibility unveils growth of thermodynamic amorphous order in glass-formers. [electronic resource] by
- Albert, S
- Bauer, Th
- Michl, M
- Biroli, G
- Bouchaud, J-P
- Loidl, A
- Lunkenheimer, P
- Tourbot, R
- Wiertel-Gasquet, C
- Ladieu, F
Producer: 20160708
In:
Science (New York, N.Y.) vol. 352
Availability: No items available.
|
|
|
13.
|
[Bronchial aspergillosis]. [electronic resource] by
- Dobbertin, I
- Friedel, G
- Jaki, R
- Michl, M
- Kimmich, M
- Hofmann, A
- Eulenbruch, H-P
- Weber, J
- Spengler, W
- Ott, G
- Kohlhäufl, M
Producer: 20100610
In:
Pneumologie (Stuttgart, Germany) vol. 64
Availability: No items available.
|
|
|
14.
|
Unifying different interpretations of the nonlinear response in glass-forming liquids. [electronic resource] by
- Gadige, P
- Albert, S
- Michl, M
- Bauer, Th
- Lunkenheimer, P
- Loidl, A
- Tourbot, R
- Wiertel-Gasquet, C
- Biroli, G
- Bouchaud, J-P
- Ladieu, F
Producer: 20180710
In:
Physical review. E vol. 96
Availability: No items available.
|
|
|
15.
|
Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors. [electronic resource] by
- Michl, M
- Haug, A R
- Jakobs, T F
- Paprottka, P
- Hoffmann, R-T
- Bartenstein, P
- Boeck, S
- Haas, M
- Laubender, R P
- Heinemann, V
Producer: 20140319
In:
Oncology vol. 86
Availability: No items available.
|
|
|
16.
|
A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer. [electronic resource] by
- Heinemann, V
- Di Gioia, D
- Vehling-Kaiser, U
- Harich, H-D
- Heinrich, B
- Welt, A
- Ziske, C
- Deutsch, G
- Pihusch, R
- Kölbl, H
- Hegewisch-Becker, S
- Michl, M
- Stemmler, H J
Producer: 20110614
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 22
Availability: No items available.
|
|
|
17.
|
Relation of cetuximab-induced skin toxicity and early tumor shrinkage in metastatic colorectal cancer patients: results of the randomized phase 3 trial FIRE-3 (AIO KRK0306). [electronic resource] by
- Holch, J W
- Held, S
- Stintzing, S
- Fischer von Weikersthal, L
- Decker, T
- Kiani, A
- Kaiser, F
- Heintges, T
- Kahl, C
- Kullmann, F
- Scheithauer, W
- Moehler, M
- von Einem, J C
- Michl, M
- Heinemann, V
Producer: 20210106
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 31
Availability: No items available.
|
|
|
18.
|
Relevance of baseline carcinoembryonic antigen for first-line treatment against metastatic colorectal cancer with FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). [electronic resource] by
- Holch, J W
- Ricard, I
- Stintzing, S
- Fischer von Weikersthal, L
- Decker, T
- Kiani, A
- Vehling-Kaiser, U
- Heintges, T
- Kahl, C
- Kullmann, F
- Scheithauer, W
- Moehler, M
- Jelas, I
- Modest, D P
- Westphalen, C B
- von Einem, J C
- Michl, M
- Heinemann, V
Producer: 20200504
In:
European journal of cancer (Oxford, England : 1990) vol. 106
Availability: No items available.
|
|
|
19.
|
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. [electronic resource] by
- von Einem, J C
- Heinemann, V
- von Weikersthal, L Fischer
- Vehling-Kaiser, U
- Stauch, M
- Hass, H G
- Decker, T
- Klein, S
- Held, S
- Jung, A
- Kirchner, T
- Haas, M
- Holch, J
- Michl, M
- Aubele, P
- Boeck, S
- Schulz, C
- Giessen, C
- Stintzing, S
- Modest, D P
Producer: 20141103
In:
Journal of cancer research and clinical oncology vol. 140
Availability: No items available.
|
|
|
20.
|
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial). [electronic resource] by
- Michl, M
- Stintzing, S
- Fischer von Weikersthal, L
- Decker, T
- Kiani, A
- Vehling-Kaiser, U
- Al-Batran, S-E
- Heintges, T
- Lerchenmueller, C
- Kahl, C
- Seipelt, G
- Kullmann, F
- Stauch, M
- Scheithauer, W
- Hielscher, J
- Scholz, M
- Mueller, S
- Lerch, M M
- Modest, D P
- Kirchner, T
- Jung, A
- Heinemann, V
Producer: 20171226
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 27
Availability: No items available.
|